References from Glucagon-Like Peptide-1 Receptor Agonists in Obesity: Evidence for Dose Reduction and Durable Weight Loss Maintenance. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Glucagon-Like Peptide-1 Receptor Agonists in Obesity: Evidence for Dose Reduction and Durable Weight Loss Maintenance | ResearchHub - ResearchHub
